Published in CMAJ on May 08, 2017
New Canadian guidance on opioid use for chronic pain: necessary but not sufficient. CMAJ (2017) 1.24
Role of regulators in safe prescribing of opioids. CMAJ (2017) 0.97
Inconsistencies in the 2017 Canadian Guideline for Opioids for Chronic Noncancer Pain. CMAJ (2017) 0.91
The authors respond to "Inconsistencies in the 2017 Canadian Guideline for Opioids for Chronic Noncancer Pain". CMAJ (2017) 0.75
Response to "Role of regulators in safe prescribing of opioids". CMAJ (2017) 0.75
Sensible approaches to manage the current opioid crisis. CMAJ (2017) 0.75
Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain. BMC Musculoskelet Disord (2017) 0.75
Patterns of User Engagement With the Mobile App, Manage My Pain: Results of a Data Mining Investigation. JMIR Mhealth Uhealth (2017) 0.75
Adverse outcomes associated with opioid prescription for acute low back pain: a systematic review protocol. Syst Rev (2017) 0.75
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (2008) 33.10
Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med (2010) 11.99
Going from evidence to recommendations. BMJ (2008) 7.30
CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recomm Rep (2016) 3.70
GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol (2013) 3.58
Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res (2006) 3.28
Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population. Can Fam Physician (2011) 2.69
Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid. J Clin Epidemiol (2011) 2.69
GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol (2013) 2.46
Nonmedical Prescription Opioid Use and Use Disorders Among Adults Aged 18 Through 64 Years in the United States, 2003-2013. JAMA (2015) 2.14
Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Physician (2012) 2.13
The need for a Canadian pain strategy. Pain Res Manag (2011) 1.98
Addressing the limitations of the CDC guideline for prescribing opioids for chronic noncancer pain. CMAJ (2016) 1.77
Decision aids that really promote shared decision making: the pace quickens. BMJ (2015) 1.51
High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study. PLoS One (2016) 1.46
Creating clinical practice guidelines we can trust, use, and share: a new era is imminent. Chest (2013) 1.42
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance. Pain Physician (2012) 1.42
Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome. Aliment Pharmacol Ther (2008) 1.32
The prevalence of chronic pain and pain-related interference in the Canadian population from 1994 to 2008. Chronic Dis Inj Can (2011) 1.30
Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009. Drug Alcohol Depend (2010) 1.26
Opioid use behaviors, mental health and pain--development of a typology of chronic pain patients. Drug Alcohol Depend (2009) 1.19
Significant pain reduction in chronic pain patients after detoxification from high-dose opioids. J Opioid Manag (2007) 1.16
Trustworthy clinical guidelines. Ann Intern Med (2011) 1.16
Economic implications of pain management. Acta Anaesthesiol Scand (1999) 1.11
Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study. Dig Dis Sci (1995) 1.10
Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study. PLoS One (2015) 1.06
Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Curr Med Res Opin (2006) 0.98
Long-term opioid therapy, aberrant behaviors, and substance misuse: comparison of patients treated by resident and attending physicians in a general medical clinic. J Opioid Manag (2012) 0.93
Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain. J Opioid Manag (2008) 0.93
ACOEM practice guidelines: opioids for treatment of acute, subacute, chronic, and postoperative pain. J Occup Environ Med (2014) 0.91
Utah clinical guidelines on prescribing opioids for treatment of pain. J Pain Palliat Care Pharmacother (2010) 0.90
Self-reported practices in opioid management of chronic noncancer pain: a survey of Canadian family physicians. Pain Res Manag (2013) 0.89
Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial. Am J Ther (2011) 0.87
Effective Canadian policy to reduce harms from prescription opioids: learning from past failures. CMAJ (2016) 0.87
Automated prediction of risk for problem opioid use in a primary care setting. J Pain (2015) 0.86
Prescription Opioid Use, Harms and Interventions in Canada: A Review Update of New Developments and Findings since 2010. Pain Physician (2015) 0.85
Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2). Pain Physician (2017) 0.83
A synthesis of oral morphine equivalents (OME) for opioid utilisation studies. Pharmacoepidemiol Drug Saf (2015) 0.81
Clinical Implications of Tapering Chronic Opioids in a Veteran Population. Pain Med (2015) 0.81
Results of a double-blind, placebo-controlled, fixed-dose assessment of once-daily OROS® hydromorphone ER in patients with moderate to severe pain associated with chronic osteoarthritis. Pain Pract (2012) 0.81
Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group. J Clin Epidemiol (2016) 0.80
Attitudes toward the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain: A qualitative study. J Opioid Manag (2017) 0.79
Health utilities in people with chronic pain using a population-level survey and linked healthcare administrative data. Pain (2016) 0.79